Kissei Pharmaceutical Co., Ltd. (4547.T)
JPY 3515.0
(0.14%)
JPY 3515.0
(0.14%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 260.92 Billion JPY | 17.96% |
| 2022 | 221.2 Billion JPY | -7.09% |
| 2021 | 238.08 Billion JPY | -11.45% |
| 2020 | 268.86 Billion JPY | 15.99% |
| 2019 | 231.79 Billion JPY | 8.56% |
| 2018 | 213.52 Billion JPY | 0.2% |
| 2017 | 213.08 Billion JPY | 14.07% |
| 2016 | 186.8 Billion JPY | -3.38% |
| 2015 | 193.34 Billion JPY | 6.54% |
| 2014 | 181.48 Billion JPY | 5.12% |
| 2013 | 172.64 Billion JPY | 7.89% |
| 2012 | 160.02 Billion JPY | 10.83% |
| 2011 | 144.38 Billion JPY | -1.27% |
| 2010 | 146.24 Billion JPY | -0.53% |
| 2009 | 147.02 Billion JPY | 4.88% |
| 2008 | 140.18 Billion JPY | -6.9% |
| 2007 | 150.56 Billion JPY | -7.96% |
| 2006 | 163.58 Billion JPY | -6.05% |
| 2005 | 174.11 Billion JPY | 5.56% |
| 2004 | 164.94 Billion JPY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 260.33 Billion JPY | 0.94% |
| 2024 Q1 | 257.91 Billion JPY | -1.16% |
| 2023 Q4 | 260.92 Billion JPY | 14.22% |
| 2023 FY | 260.92 Billion JPY | 17.96% |
| 2023 Q3 | 228.45 Billion JPY | -1.48% |
| 2023 Q1 | 225.41 Billion JPY | 1.9% |
| 2023 Q2 | 231.87 Billion JPY | 2.87% |
| 2022 Q3 | 230.39 Billion JPY | -1.37% |
| 2022 Q4 | 221.2 Billion JPY | -3.99% |
| 2022 FY | 221.2 Billion JPY | -7.09% |
| 2022 Q1 | 235.34 Billion JPY | -1.15% |
| 2022 Q2 | 233.58 Billion JPY | -0.75% |
| 2021 FY | 238.08 Billion JPY | -11.45% |
| 2021 Q2 | 251.05 Billion JPY | -3.89% |
| 2021 Q4 | 238.08 Billion JPY | -0.62% |
| 2021 Q1 | 261.2 Billion JPY | -2.85% |
| 2021 Q3 | 239.57 Billion JPY | -4.57% |
| 2020 Q1 | 260.68 Billion JPY | 12.46% |
| 2020 Q4 | 268.86 Billion JPY | 2.43% |
| 2020 FY | 268.86 Billion JPY | 15.99% |
| 2020 Q2 | 266.48 Billion JPY | 2.23% |
| 2020 Q3 | 262.47 Billion JPY | -1.5% |
| 2019 Q1 | 210 Billion JPY | -1.65% |
| 2019 Q3 | 229.29 Billion JPY | 3.8% |
| 2019 Q4 | 231.79 Billion JPY | 1.09% |
| 2019 Q2 | 220.9 Billion JPY | 5.19% |
| 2019 FY | 231.79 Billion JPY | 8.56% |
| 2018 FY | 213.52 Billion JPY | 0.2% |
| 2018 Q4 | 213.52 Billion JPY | 5.75% |
| 2018 Q3 | 201.91 Billion JPY | -9.15% |
| 2018 Q1 | 211.45 Billion JPY | -0.76% |
| 2018 Q2 | 222.25 Billion JPY | 5.11% |
| 2017 Q3 | 211.63 Billion JPY | 6.81% |
| 2017 Q1 | 191.32 Billion JPY | 2.42% |
| 2017 Q4 | 213.08 Billion JPY | 0.68% |
| 2017 FY | 213.08 Billion JPY | 14.07% |
| 2017 Q2 | 198.15 Billion JPY | 3.57% |
| 2016 Q2 | 186.94 Billion JPY | -1.31% |
| 2016 Q3 | 187.23 Billion JPY | 0.16% |
| 2016 FY | 186.8 Billion JPY | -3.38% |
| 2016 Q1 | 189.43 Billion JPY | -2.02% |
| 2016 Q4 | 186.8 Billion JPY | -0.23% |
| 2015 Q3 | 191.54 Billion JPY | 7.33% |
| 2015 Q2 | 178.45 Billion JPY | -2.95% |
| 2015 Q1 | 183.89 Billion JPY | 1.33% |
| 2015 FY | 193.34 Billion JPY | 6.54% |
| 2015 Q4 | 193.34 Billion JPY | 0.94% |
| 2014 Q2 | 178.99 Billion JPY | 3.61% |
| 2014 Q3 | 171.36 Billion JPY | -4.26% |
| 2014 FY | 181.48 Billion JPY | 5.12% |
| 2014 Q4 | 181.48 Billion JPY | 5.9% |
| 2014 Q1 | 172.75 Billion JPY | 0.06% |
| 2013 Q1 | 158.73 Billion JPY | -0.81% |
| 2013 Q3 | 171.08 Billion JPY | 6.1% |
| 2013 Q4 | 172.64 Billion JPY | 0.91% |
| 2013 FY | 172.64 Billion JPY | 7.89% |
| 2013 Q2 | 161.24 Billion JPY | 1.58% |
| 2012 Q3 | 147.86 Billion JPY | 1.37% |
| 2012 Q2 | 145.86 Billion JPY | 1.07% |
| 2012 FY | 160.02 Billion JPY | 10.83% |
| 2012 Q1 | 144.32 Billion JPY | -0.04% |
| 2012 Q4 | 160.02 Billion JPY | 8.22% |
| 2011 FY | 144.38 Billion JPY | -1.27% |
| 2011 Q4 | 144.38 Billion JPY | 2.01% |
| 2011 Q2 | 142.93 Billion JPY | -1.07% |
| 2011 Q1 | 144.48 Billion JPY | -1.21% |
| 2011 Q3 | 141.53 Billion JPY | -0.98% |
| 2010 Q3 | 143.6 Billion JPY | 0.54% |
| 2010 FY | 146.24 Billion JPY | -0.53% |
| 2010 Q4 | 146.24 Billion JPY | 1.84% |
| 2010 Q2 | 142.83 Billion JPY | -2.07% |
| 2010 Q1 | 145.86 Billion JPY | -0.79% |
| 2009 Q3 | 144.84 Billion JPY | 0.61% |
| 2009 Q2 | 143.97 Billion JPY | 0.0% |
| 2009 FY | 147.02 Billion JPY | 4.88% |
| 2009 Q4 | 147.02 Billion JPY | 1.5% |
| 2008 Q3 | 141.89 Billion JPY | 0.0% |
| 2008 FY | 140.18 Billion JPY | -6.9% |
| 2008 Q4 | 140.18 Billion JPY | -1.21% |
| 2007 FY | 150.56 Billion JPY | -7.96% |
| 2006 FY | 163.58 Billion JPY | -6.05% |
| 2005 FY | 174.11 Billion JPY | 5.56% |
| 2004 FY | 164.94 Billion JPY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 36.57 Billion JPY | -613.447% |
| Takeda Pharmaceutical Company Limited | 15108.79 Billion JPY | 98.273% |
| Sumitomo Pharma Co., Ltd. | 907.5 Billion JPY | 71.248% |
| Shionogi & Co., Ltd. | 1416.91 Billion JPY | 81.585% |
| Wakamoto Pharmaceutical Co.,Ltd. | 15.42 Billion JPY | -1592.031% |
| Nippon Shinyaku Co., Ltd. | 263.4 Billion JPY | 0.94% |
| Kaken Pharmaceutical Co., Ltd. | 171.62 Billion JPY | -52.036% |
| Eisai Co., Ltd. | 1393.79 Billion JPY | 81.279% |
| Morishita Jintan Co., Ltd. | 17.18 Billion JPY | -1418.53% |
| Hisamitsu Pharmaceutical Co., Inc. | 328.77 Billion JPY | 20.637% |
| Mochida Pharmaceutical Co., Ltd. | 158.8 Billion JPY | -64.313% |
| Fuso Pharmaceutical Industries,Ltd. | 76.46 Billion JPY | -241.262% |
| Nippon Chemiphar Co., Ltd. | 49.54 Billion JPY | -426.619% |
| Tsumura & Co. | 428.25 Billion JPY | 39.071% |
| Torii Pharmaceutical Co., Ltd. | 133.43 Billion JPY | -95.552% |
| Towa Pharmaceutical Co., Ltd. | 430.65 Billion JPY | 39.411% |
| Fuji Pharma Co., Ltd. | 85.33 Billion JPY | -205.781% |
| Zeria Pharmaceutical Co., Ltd. | 150.53 Billion JPY | -73.336% |
| KYORIN Holdings, Inc. | 177.67 Billion JPY | -46.854% |
| Taiko Pharmaceutical Co.,Ltd. | 15.04 Billion JPY | -1634.208% |
| Daito Pharmaceutical Co.,Ltd. | 77.7 Billion JPY | -235.781% |
| SymBio Pharmaceuticals Limited | 15.35 Billion JPY | -1599.637% |
| MedRx Co., Ltd | 2.05 Billion JPY | -12615.838% |
| Mizuho Medy Co.,Ltd. | 18.94 Billion JPY | -1277.056% |
| Solasia Pharma K.K. | 2.55 Billion JPY | -10132.51% |
| Modalis Therapeutics Corporation | 2.02 Billion JPY | -12779.499% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 93.31 Billion JPY | -179.631% |
| Sawai Group Holdings Co., Ltd. | 382.02 Billion JPY | 31.698% |
| Cyfuse Biomedical K.K. | 4.21 Billion JPY | -6090.767% |
| Toho Holdings Co., Ltd. | 773.42 Billion JPY | 66.263% |
| Koa Shoji Holdings Co.,Ltd. | 32 Billion JPY | -715.301% |